Entero Therapeutics Inc

Research Entero Therapeutics Inc (GRDX) on Bullrun: market cap USD 29.67M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGRDX
• ExchangeNASDAQ
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 29.67M
• Financial periodFY2025
• RevenueUSD 36.25K
• Net income-USD 6.39M
• Gross margin-1813.6%

Valuation Snapshot

latest market cap is USD 29.67M.

About Entero Therapeutics Inc

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Frequently asked questions

What is Entero Therapeutics Inc's market cap?

Entero Therapeutics Inc's market capitalization is USD 29.67M.

What does Entero Therapeutics Inc do?

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources.